The "ALX4 Gene Parietal Foramina Type 2 Genetic Test" is a specialized diagnostic procedure designed to identify mutations in the ALX4 gene, which are associated with the development of Parietal Foramina Type 2, a rare genetic condition. This condition is characterized by the incomplete closure of the skull bones, specifically at the parietal bones, leading to foramina, or gaps, which can vary in size. These gaps are typically symptomless but can be associated with other cranial or neurological abnormalities in some cases.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, this test is crucial for individuals with a family history of Parietal Foramina or related symptoms. It provides essential genetic insights that can aid in the accurate diagnosis, management, and understanding of the condition's inheritance patterns. The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed for specific mutations in the ALX4 gene that are indicative of Parietal Foramina Type 2.
The cost of the ALX4 Gene Parietal Foramina Type 2 Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive nature of the test, including the advanced genetic sequencing and analysis required to detect mutations accurately. While the cost may seem significant, the value of the information it provides for affected individuals and their families can be invaluable, offering insights that facilitate informed medical and personal decisions regarding the condition.
The SNCA Gene PARK1 Parkinson Genetic Test is a specialized diagnostic tool used to detect mutations in the SNCA gene, which are strongly associated with the development of Parkinson's disease. Parkinson's disease is a progressive neurological disorder characterized by tremors, stiffness, and difficulty with balance and coordination. The SNCA gene plays a crucial role in the production of alpha-synuclein, a protein that, when mutated, can lead to the formation of abnormal protein deposits in the brain, a hallmark of Parkinson's disease.
This genetic test is particularly important for individuals with a family history of Parkinson's disease or those showing early symptoms, as it can provide valuable information regarding their risk of developing the condition. Early detection through genetic testing can enable proactive management of the disease, potentially improving quality of life.
The test is available at DNA Labs UAE, a leading facility in genetic diagnostics and research. DNA Labs UAE utilizes state-of-the-art technology to ensure accurate and reliable results. The cost of the SNCA Gene PARK1 Parkinson Genetic Test is 4400 AED, reflecting the comprehensive analysis and expertise required to interpret the results. By choosing to undergo this test at DNA Labs UAE, individuals gain access to crucial genetic information that can inform their healthcare decisions and potentially lead to early intervention strategies for Parkinson's disease.
The HTRA2 Gene PARK13 Parkinson Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the HTRA2 gene, which have been associated with the development of Parkinson's disease. This test is particularly significant for individuals with a family history of Parkinson's disease or those exhibiting early symptoms, as it provides crucial genetic information that can aid in the early diagnosis and management of this neurodegenerative disorder.
Parkinson's disease is a progressive neurological condition characterized by tremors, stiffness, and difficulty with balance and coordination. The HTRA2 gene, also known as PARK13, plays a vital role in mitochondrial function and the regulation of cell death, with mutations in this gene linked to increased susceptibility to Parkinson's disease. By analyzing the genetic makeup of the HTRA2 gene, the test can identify specific mutations that may increase an individual's risk of developing Parkinson's disease.
Conducted at the state-of-the-art facilities of DNA Labs UAE, the test is priced at 4400 AED. The process involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of mutations in the HTRA2 gene. Results from the test can provide valuable insights into an individual's risk of developing Parkinson's disease, enabling healthcare providers to tailor early intervention strategies and potentially improve patient outcomes.
The HTRA2 Gene PARK13 Parkinson Genetic Test is an important resource for individuals seeking to understand their genetic risk for Parkinson's disease and for healthcare professionals aiming to provide targeted care for their patients.
The FBXO7 Gene PARK15 Parkinson Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the FBXO7 gene, which have been linked to a rare form of hereditary Parkinson's disease known as PARK15. Parkinson's disease is a progressive neurological disorder that affects movement, causing symptoms such as tremors, stiffness, and balance problems. The PARK15 form of the disease is characterized by its early onset and rapid progression, making early detection crucial for managing symptoms and planning treatment.
The test involves analyzing the patient's DNA to detect specific mutations in the FBXO7 gene that are responsible for PARK15. It is particularly recommended for individuals with a family history of Parkinson's disease or those showing early symptoms of the disorder. By identifying these genetic markers, healthcare providers can confirm a diagnosis of PARK15, differentiate it from other forms of Parkinson's disease, and tailor treatment plans to the patient's specific condition.
At DNA Labs UAE, the FBXO7 Gene PARK15 Parkinson Genetic Test is offered at a cost of 4400 AED. The process is conducted by experienced professionals using state-of-the-art technology to ensure accurate and reliable results. Patients opting for this test can expect a comprehensive analysis, with results that provide crucial insights into their condition and how best to manage it.
The VPS35 Gene PARK17 Parkinson Genetic Test is a specialized diagnostic examination designed to detect mutations in the VPS35 gene, which have been associated with an increased risk of developing Parkinson's disease. This test is particularly crucial for individuals who have a family history of Parkinson's or exhibit early symptoms of the disease, as it can provide valuable insights into their genetic predisposition to this neurodegenerative disorder. Conducted at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample from the patient, usually through a blood draw or cheek swab, and analyzing it for specific mutations in the VPS35 gene linked to Parkinson's disease. The cost of the VPS35 Gene PARK17 Parkinson Genetic Test is 4400 AED, reflecting the sophisticated technology and expert analysis involved in identifying these genetic markers. By opting for this test, individuals can gain early awareness of their risk, enabling them to make informed decisions about their health and potentially access early interventions or personalized management plans to mitigate the impact of Parkinson's disease.
The DNAJC6 gene, associated with PARK19, is linked to a form of juvenile-onset Parkinson's disease, a neurological disorder characterized by movement difficulties, muscle rigidity, and tremors. This particular gene plays a crucial role in the health and function of neurons in the brain. Mutations in DNAJC6 can lead to the early development of Parkinson's disease symptoms, often before the age of 40.
To diagnose this condition and assess the risk in individuals with a family history of juvenile-onset Parkinson's disease, genetic testing is available. DNA Labs UAE offers a comprehensive test targeting the DNAJC6 gene to identify mutations that are associated with PARK19. This test is crucial for early diagnosis and management of the condition, enabling healthcare providers to tailor treatment plans to the individual's genetic profile.
The cost of the DNAJC6 Gene PARK19 Parkinson Juvenile-Onset Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the expenses of the genetic analysis and the provision of a detailed report by the lab's geneticists. The report not only offers insights into the individual's genetic predisposition to developing Parkinson's disease but also provides valuable information for family planning and the possibility of genetic counseling for relatives.
Overall, this genetic test represents a significant step forward in the personalized medicine approach to treating neurological disorders, offering hope and actionable insights to individuals and families affected by juvenile-onset Parkinson's disease.
The PRKN Gene (PARK2) Parkinson Genetic Test is a specialized diagnostic procedure designed to identify mutations in the PARK2 gene, which is closely associated with the development of Parkinson's disease. This test is crucial for individuals who have a family history of Parkinson's disease or exhibit early symptoms, as it can provide vital information regarding their risk of developing the condition.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing it for specific genetic alterations in the PARK2 gene. These mutations are known to cause the early onset of Parkinson's disease by affecting the function of the protein parkin, which plays a significant role in the degradation of unwanted proteins in brain cells.
The cost of the PRKN Gene (PARK2) Parkinson Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the sophisticated technology and expertise required to accurately identify mutations in the PARK2 gene. For individuals at risk, this test provides invaluable insights into their genetic predisposition to Parkinson's disease, enabling them to make informed decisions about their health and future.
The SYNJ1 Gene PARK20 Parkinson Genetic Test is a specialized genetic test offered by DNA Labs UAE, designed to identify mutations in the SYNJ1 gene that are associated with Parkinson's disease type 20 (PARK20). This form of Parkinson's disease is rare and typically follows an autosomal recessive pattern of inheritance, meaning that two copies of the mutated gene, one from each parent, are necessary for the disease to manifest.
This test is crucial for individuals who have a family history of Parkinson's disease or exhibit early symptoms of the condition, as it can provide definitive genetic evidence of the presence of the specific mutations linked to PARK20. The outcome of the test can aid in the early diagnosis of the condition, enabling timely intervention and management strategies that can significantly improve the quality of life for affected individuals.
The cost of the SYNJ1 Gene PARK20 Parkinson Genetic Test at DNA Labs UAE is 4400 AED. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of mutations in the SYNJ1 gene. The results of this test not only offer valuable information for the individual tested but can also provide important genetic insights for their family members, guiding future genetic counseling and testing decisions.
Given the complex nature of genetic testing and the implications of the results, individuals considering this test are advised to undergo genetic counseling before and after testing to fully understand the potential outcomes and their impact on health and family planning decisions.
The PINK1 Gene PARK6 Parkinson Genetic Test is a specialized diagnostic examination designed to detect mutations in the PTEN-induced kinase 1 (PINK1) gene, which is associated with PARK6, a form of early-onset Parkinson's disease. This genetic test is crucial for individuals with a family history of Parkinson's disease or those who exhibit symptoms at an early age, as it can provide definitive information regarding their genetic predisposition to this form of the condition. Conducted at DNA Labs UAE, a leading facility in genetic testing, the test offers a comprehensive analysis to identify the specific mutations in the PINK1 gene that are linked to the development of Parkinson's disease. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify and interpret the genetic variations associated with the condition. This test not only aids in the early diagnosis and understanding of the patient's condition but also in the planning of personalized management and treatment strategies, potentially improving the quality of life for those affected by this form of Parkinson's disease.
The "EOMES Gene Neuronal Migration Disorder Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the EOMES gene, which are linked to various neuronal migration disorders. These disorders can affect brain development, leading to a range of neurological symptoms and conditions. The EOMES gene plays a crucial role in the development and migration of neurons during embryonic brain development. Mutations in this gene can disrupt normal brain formation, resulting in developmental delays, intellectual disabilities, and other neurological issues.
This genetic test involves analyzing the patient's DNA to detect any abnormalities in the EOMES gene that may be responsible for such conditions. It is a critical step in diagnosing specific neuronal migration disorders, allowing for a better understanding of the condition and enabling healthcare providers to tailor treatment and management plans more effectively.
The test is conducted at DNA Labs UAE, a facility known for its advanced genetic testing services. The cost of the EOMES Gene Neuronal Migration Disorder Genetic Test is 4400 AED, reflecting the sophisticated technology and expertise required to perform this intricate analysis. By offering this test, DNA Labs UAE provides essential support for individuals and families seeking answers to complex neurological conditions, contributing to improved patient care and outcomes in the field of genetic disorders.
